The Triple Threat: Has it changed since the last respiratory season?

Since the pandemic, there has been a triple threat of SARS-CoV-2, influenza, and respiratory syncytial virus during the respiratory seasons. Distinguishing between the three based on symptoms alone can be challenging, as they share common clinical manifestations, so diagnostic tests, including PCR and rapid antigen tests, have become crucial for accurate identification. While last year’s “tripledemic” brought a surge of influenza and RSV cases in addition to SARS-CoV-2 – how does this year’s respiratory season compare?

Aired on February 28, 2024


60-Minute Webinar Sponsored By


In 2024 SARS-CoV-2 and influenza are still present and increasing, although severe cases and hospitalizations are decreasing. Treatments for these respiratory infections are still effective, and syndromic testing might be applied in these cases, but testing for these main pathogens continues to be the primary need. We will discuss the important testing and patient care implications for this respiratory season.

Presented by industry expert Dr. Kristie Johnson, PhD, D(ABMM), this insightful program is designed to empower healthcare leaders in the medical laboratory industry to make informed decisions about their SARS-CoV-2, influenza, and RSV testing needs. 

What You'll Learn

  • Comparing trends and impacts of this year’s respiratory season to last year.
  • Discussing testing choices available for SARS-CoV-2, influenza, and RSV.
  • Evaluating the main patient management options available.
  • Important testing and patient care implications for this respiratory season.
Magnolia Header

Expert Panel

Dr. Kristie Johnson

Professor at the University of Maryland School of Medicine

Dr. Kristie Johnson, Professor at the University of Maryland School of Medicine, will lead the webinar. As the Medical Director of the Clinical Microbiology Laboratory at the University of Maryland Medical Center, Dr. Johnson is a Diplomate of the American Board of Medical Microbiology. Her expertise lies in the diagnosis of infectious diseases, focusing on detection, transmission, and control of infectious diseases, including antimicrobial-resistant organisms.

Who should attend?

  • Laboratory Directors and Administrators
  • Microbiologists
  • Infection Control
  • Pharmacy/Stewardship
  • Molecular Laboratory Directors
  • Pathologists

Hosted By

dark daily logo-no tags-FIT-white